| [1] |
Irimie A, Achimas-Cadariu P, Burz C, et al. Multiple primary malignancies: epidemiological analysis at a single tertiary institution[J]. J Gastrointestin Liver Dis, 2010, 19(1): 69-73.
|
| [2] |
Wu C, Bai DS, Jiang GQ, et al. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature[J]. World J Surg Oncol, 2014, 12: 337. DOI: 10.1186/1477-7819-12-337.
|
| [3] |
|
| [4] |
Legué LM, Bernards N, Gerritse SL, et al. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands[J]. Acta Oncol, 2016, 55(9-10): 1183-1189. DOI: 10.1080/0284186X.2016.1182211.
|
| [5] |
Alawyia B, Constantinou C. Hepatocellular carcinoma: a narrative review on current knowledge and future prospects[J]. Curr Treat Options Oncol, 2023, 24(7): 711-724. DOI: 10.1007/s11864-023-01098-9.
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
Wen G, Gu J, Zhou W, et al. Benefits of 18F-FDG PET/CT for the preoperative characterisation or staging of disease in the ampullary and duodenal papillary[J]. Eur Radiol, 2020, 30(9): 5089-5098. DOI: 10.1007/s00330-020-06864-z.
|
| [10] |
Foglia B, Turato C, Cannito S. Hepatocellular carcinoma: latest research in pathogenesis, detection and treatment[J]. Int J Mol Sci, 2023, 24(15): 12224. DOI: 10.3390/ijms241512224.
|
| [11] |
|
| [12] |
Lv Y, Wang P, Chen J, et al. Indicative value of pathological classification of duodenal papillary adenomas in clinical diagnosis and treatment[J]. Surg Endosc, 2022, 36(7): 5183-5197. DOI: 10.1007/s00464-021-08894-0.
|
| [13] |
Xu M, Wu J, Yu L, et al. Surgical versus endoscopic resection of large sessile duodenal and papillary lesions[J]. Eur J Gastroenterol Hepatol, 2020, 32(1): 48-53. DOI: 10.1097/MEG.0000000000001577.
|
| [14] |
Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition)[J]. Liver Cancer, 2020, 9(6): 682-720. DOI: 10.1159/000509424.
|
| [15] |
Llovet JM, De Baere T, Kulik L, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(5): 293-313. DOI: 10.1038/s41575-020-00395-0.
|